Format

Send to

Choose Destination
Urologe A. 2007 Jul;46(7):727-8, 730-2.

[The latest news on bladder cancer].

[Article in German]

Author information

1
Urologische Klinik und Poliklinik der Technischen Universität München, München. margitta.retz@lrz.tum.de

Abstract

A review of the current literature provides new scientific insights into the diagnosis, prognosis and novel molecular targets for bladder cancer. The new WHO classification refines our staging system and influences treatment options. International clinical databases provide new tools for calculating the individual risk for bladder cancer recurrence and progression. Systematic gene cluster analysis defines multimarker panels that can serve as robust predictors of outcome. Discoveries of new signaling pathways in bladder cancer are leading to novel molecular targets for innovative therapies.

PMID:
17576529
DOI:
10.1007/s00120-007-1370-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center